oxide

Brexpiprazole S-oxide D8 (DM-3411 D8) is a deuterium-labeled Brexpiprazole S-oxide, the primary metabolite of Brexpiprazole, which is a partial agonist of human 5-HT1A and dopamine receptors (Kis: 0.12 nM and 0.3 nM).

Brexpiprazole S-oxide (DM-3411), a primary metabolite of Brexpiprazole, acts as a partial agonist of human 5-HT1A and dopamine receptors with Ki values of 0.12 nM and 0.3 nM, respectively.

Dofetilide N-oxide (UK-116856), a metabolite of dofetilide, is associated with the parent compound's ability to block potassium channels, categorizing it as a tertiary antiarrhythmic drug.

Gefitinib is an EGFR tyrosine kinase inhibitor, with IC50 of 2-37 nM in NR6wtEGFR cells. Gefitinib N-oxide is the N-oxide derivative of Gefitinib.

Netupitant N-oxide is a highly selective antagonist of NK1 receptor, is Netupitant metabolite.

Trimetazidine-N-oxide, the major active metabolite of Trimetazidine, is a selective long-chain inhibitor of 3-ketoyl coenzyme A thiolase (IC50: 75 nM) with anti-oxidant, anti-inflammatory, antinociceptive, and gastroprotective properties.

Acetylseneciphylline N-oxide, a pyrrolizine alkaloid, is characterized by its toxicological properties and is commonly found in certain plant species.

Raloxifene N-Oxide is an oxidative degradation product of Raloxifene.

Trimethoprim N-oxide is a human urinary metabolite.

Fenbutatin oxide is an organometallic insecticide chemical. It mainly used in agricultural practices to kill ticks and mites.

Ranitidine-S-oxide is a metabolite of Ranitidine. It is commonly used in the treatment of peptic ulcer disease, Zollinger–Ellison syndrome，and gastroesophageal reflux disease.

Lignocaine N-oxide is a metabolite of Lidocaine, which is an antiarrhythmic and anesthetic agent.

Ranitidine-N-oxide is a metabolite of Ranitidine. Ranitidine is a antagonist of histamine H2-receptor, it inhibits the normal and meal-stimulated secretion of stomach acid. Ranitidine is a medication decreaseing stomach acid production.

Atropine Oxide is a derivative of Atropine. Atropine is a competitive antagonist of the muscarinic acetylcholine receptor types M1, M2, M3, M4, and M5. Atropine is a medication to treat certain types of nerve agents and pesticide poisonings as well as som

Lasiocarpine N-oxide, a natural compound, has been identified at higher concentrations in many tea bags, herbal drugs, and honey via mass spectrometry.

Capramidopropylamine oxide is a biochemical.

Isatidine is a pyrrolizidine alkaoid.

Piperitenone oxide is a major chemical constituent of the carvone pathway MS essential oil.

Sorafenib N-oxide is an active metabolite of sorafenib , an inhibitor of Raf-1, B-RAF, and receptor tyrosine kinases. Sorafenib N-oxide inhibits FLT3 that contains the internal tandem duplication mutation (FLT3-ITD; Kd = 70 nM) and inhibits proliferation of MV4-11 acute myeloid leukemia (AML) cells expressing FLT3-ITD (IC50 = 25.8 nM). It is selective for AML cell lines containing FLT3-ITD over lines containing wild-type FLT3 (IC50s = 3.9-13.3 μM). Sorafenib N-oxide is also a linear-mixed inhibitor of the cytochrome P450 (CYP) isoform CYP3A4 (Ki = 15 μM in human liver microsomes).

Voriconazole N-oxide is a major metabolite of the triazole antifungal voriconazole . It is formed via oxidation of voriconazole by the cytochrome P450 (CYP) isoforms CYP3A4 and CYP2C19.

Echimidine N-oxide, a pyrrolizidine alkaloid, exhibits significant inhibitory activity against acetylcholinesterase (AChE) with an IC50 value of 0.347 mM.

Indicine N-oxide (NSC 132319), a pyrrolizidine alkaloid, serves as an antitumor agent in pediatric cancer and solid tumors research.

Heliotrine N-oxide is the pyrrolizidine alkaloid (PA) N-oxide counterpart of Heliotrine. It induces the generation of pyrrolic DNA adducts, potentially initiating PA-induced liver tumors in vivo.

Loratadine N-oxide is a metabolite of the histamine H1 receptor inverse agonist loratadine.